ArticleDiabetology & metabolic syndrome2025
The relation between tirzepatide and adverse cardiovascular events or renal adverse events: a meta-analysis based on randomized controlled trials.
Lishen Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.